Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
about
CIViC databaseDown-Regulation of MicroRNA-210 Confers Sensitivity towards 1'S-1'-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network.From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma.Down-regulation of miR-146a-5p and its potential targets in hepatocellular carcinoma validated by a TCGA- and GEO-based study.SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.A genetic interaction analysis identifies cancer drivers that modify EGFR dependency.Somatic Host Cell Alterations in HPV Carcinogenesis.Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma.Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics.miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance.
P2860
Q27612411-803BA401-78FD-4323-BF40-CF2D28642FAFQ33654659-3F707081-1F78-42E0-A012-5315542708DAQ36138884-C27CF738-E9CA-4A7F-B718-A1F80A382CA6Q36313998-D71DCE6E-394A-4203-92CC-5A6A93111FCEQ37734809-864D56F2-73CA-4A67-B3E6-E17EA9BDEFD9Q38702971-FF5369E4-B34C-402B-9C80-F9D3988B5DE8Q38717620-AB274EA3-E5B6-4569-A7DC-0FC75B5A45B3Q40096622-E1159099-8B37-4C4A-82EE-8D4C4544ED2FQ47329309-858EE7E3-9D0B-4ACE-925D-8C159FCEACCCQ47594961-6655FC52-6AE9-4751-8D91-FAB9496EE621Q52670018-870E9C1C-12D0-4DF3-B1DC-E7E9E430C224Q54964630-A21F8882-0B95-4463-8D5A-68A04A94FA0B
P2860
Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@ast
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@en
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@nl
type
label
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@ast
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@en
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@nl
altLabel
Decreased SMAD4 expression is ...... d neck squamous cell carcinoma
@en
prefLabel
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@ast
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@en
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P921
P1476
Decreased SMAD4 expression is ...... neck squamous cell carcinoma.
@en
P2093
Christine H Chung
Gabriel Krigsfeld
Haixia Cheng
Hiromitsu Hatakeyama
Hiroyuki Ozawa
Jason D Howard
Jimena Perez
Manjusha Thakar
Michael Considine
P2860
P304
P356
10.1080/15384047.2015.1056418
P577
2015-01-01T00:00:00Z